Dexmedetomidine: a new option for intractable distress in the dying.
Luiz Guilherme L
LG
Soares
Cláudia
C
Naylor
Maurílio A
MA
Martins
Geralda
G
Peixoto
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D000328:Adult; D020927:Dexmedetomidine / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology* / Q000523:psychology; D010148:Intractable Pain / Q000188:drug therapy*; D010166:Palliative Care / Q000379:methods*
D000316:Adrenergic alpha-Agonists; D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine